Senior Director, Corporate Accounts

Summary

Join Nuvalent, a dynamic early-stage company in oncology drug development, as the Senior Director of Corporate Accounts. Reporting to the Senior Director, Market Access & Trade Relations, you will lead a team focused on launch planning for multiple TKIs in the NSCLC market and manage individual payer accounts. This player/coach role requires developing and implementing strategic engagement plans for payers, building relationships with key stakeholders, and minimizing access barriers to Nuvalent's products. You will collaborate extensively with internal and external stakeholders, shaping the company's brand perception and ensuring optimal patient access. A significant portion of the role involves direct customer interaction (70%), while the remaining time is dedicated to internal collaboration (30%). This position is crucial for the company's growth and success in meeting patient needs.

Requirements

• Bachelor’s degree
• 10+ years of proven success in biopharma roles
• 5+ years commercial oncology experience in the US market including roles in market access with National and Regional Payer Account responsibility
• Demonstrated organizational skills to manage multiple projects simultaneously, prioritize projects effectively and communicate at all levels within the company
• Strong written and verbal communication skills (including presentation skills)
• Up to 50% domestic travel

Responsibilities

• In coordination with Market Access and Commercial Leadership, develops a payer strategy aligned with Nuvalent’s commercial goals and ensures a comprehensive tactical plan is built and deployed to achieve commercial strategic objectives
• Develop payer (engagement, insight, and contracting) and field reimbursement (remit and resourcing) strategy and plan
• Serve as subject matter expert for the Nuvalent enterprise on payer policy and health care reform trends (Nuvalent point of contact for AMCP and PCMA)
• In collaboration with market access marketing, Identify and develop payer and reimbursement opportunities that align to brand strategy
• Responsible for payer insights, including up-to-date policy coverage resource for health plans
• Responsible to partner with internal stakeholders (SP, Hub, Account Team) in support of denial management, appeals, payer education, and payer communication
• Collaborate with Medical Affairs on Guideline and Pathways Strategy
• Develop the roles, recruit, on-board, train, and lead a team of corporate account directors and field reimbursement specialists
• Create a cohesive and impactful environment for team members to make an impact, develop and thrive as an integrated, collaborative team within commercial and Nuvalent
• Serve as the primary contact for specific national and regional payers
• Develop account plans to ensure optimal and on-label patient access to Nuvalent products in a competitive and dynamic marketplace
• Develop and engage with key decision makers (medical directors, pharmacy directors) at payer entities (commercial, government, and payer/health system entities)
• Deliver value proposition and health economic information to educate payers, formulary committees on product(s), including economic benefit, in collaboration with Field HEOR as applicable
• Proactively manage business relationships by understanding current and future trends within the payer segment
• As applicable, develop the business case, lead negotiations, and manage contract performance with target accounts based on approved strategies
• Collaborate with field teams (sales and medical) to identify any access barriers and lead mitigation of barriers to access
• Work collaboratively with Specialty Pharmacy and Patient Services partners to ensure reimbursement confidence and access in alignment with product FDA label
• Ensure compliance with Nuvalent policies and federal/state regulations
• Proactively identify issues, resolve issues, and engage appropriate resources for customer solutions

Preferred Qualifications

• MBA or equivalent degree
• Oncology, lung cancer and oral oncolytic (pharmacy benefit/Part D) experience